Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Research & Development (2016 - 2024)

Historic Research & Development for Rockwell Medical (RMTI) over the last 16 years, with Q4 2024 value amounting to $1000.0.

  • Rockwell Medical's Research & Development fell 9940.48% to $1000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $1000.0, marking a year-over-year decrease of 9946.24%. This contributed to the annual value of $19000.0 for FY2024, which is 9828.36% down from last year.
  • As of Q4 2024, Rockwell Medical's Research & Development stood at $1000.0, which was down 9940.48% from $18000.0 recorded in Q1 2024.
  • Rockwell Medical's 5-year Research & Development high stood at $2.4 million for Q2 2021, and its period low was $1000.0 during Q4 2024.
  • In the last 5 years, Rockwell Medical's Research & Development had a median value of $1.1 million in 2021 and averaged $1.0 million.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 26639.61% in 2020, then crashed by 9940.48% in 2024.
  • Over the past 5 years, Rockwell Medical's Research & Development (Quarter) stood at $1.9 million in 2020, then decreased by 27.49% to $1.4 million in 2021, then tumbled by 88.78% to $156000.0 in 2022, then rose by 7.69% to $168000.0 in 2023, then plummeted by 99.4% to $1000.0 in 2024.
  • Its Research & Development was $1000.0 in Q4 2024, compared to $18000.0 in Q1 2024 and $168000.0 in Q4 2023.